![]() 世界および米国のHIVポイントオブケア検査市場の洞察、2027年までの予測Global and United States HIV Point-of-care Testing Market Insights, Forecast to 2027 HIV Point-of-care Testingは、HIV抗体のスクリーニングに使用されます。病院、診療所、在宅医療の現場で行うことができ、数分以内に検査結果を得ることができます。 市場分析とインサイト世界および米国のHIV... もっと見る
![]()
※当ページの内容はウェブ更新時の情報です。
サマリーHIV Point-of-care Testingは、HIV抗体のスクリーニングに使用されます。病院、診療所、在宅医療の現場で行うことができ、数分以内に検査結果を得ることができます。市場分析とインサイト世界および米国のHIVポイントオブケア検査市場 当レポートでは、世界および米国のHIV Point-of-care Testing市場に焦点を当てています。 2020年の世界のHIVポイントオブケア検査市場規模はXX百万米ドルで、2021年から2027年の間にXX%のCAGRで、2027年末までにXX百万米ドルに達すると予想されています。米国では、HIV Point-of-care Testingの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX%のCAGRで成長すると予測されています。 世界のHIVポイントオブケア検査の範囲と市場規模 HIV Point-of-care Testing市場は、地域(国)別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のHIV Point-of-care Testing市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年までの地域(国)別、タイプ別、アプリケーション別の収益と予測に焦点を当てています。 米国市場では、2016年から2027年までのHIV Point-of-care Testingの市場規模をプレイヤー別、タイプ別、アプリケーション別に分析しています。主要なプレイヤーには、アメリカ合衆国で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。 タイプ別セグメント 検査機器 検査試薬 アプリケーション別セグメント 病院 クリニック 在宅医療施設 地域別 北アメリカ U.S. カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア アジアパシフィック 中国 日本 韓国 インド オーストラリア 台湾 インドネシア タイ マレーシア フィリピン ベトナム ラテンアメリカ メキシコ ブラジル アルゼンチン 中近東・アフリカ トルコ サウジアラビア U.A.E. 会社別 アボット BD バイオメリュー アダルティス ロシュ 目次1 Study Coverage1.1 HIV Point-of-care Testing Product Introduction 1.2 Market by Type 1.2.1 Global HIV Point-of-care Testing Market Size Growth Rate by Type 1.2.2 Testing Equipment 1.2.3 Testing Reagent 1.3 Market by Application 1.3.1 Global HIV Point-of-care Testing Market Size Growth Rate by Application 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Home Care Setting 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global HIV Point-of-care Testing Market Size, Estimates and Forecasts 2.1.1 Global HIV Point-of-care Testing Revenue 2016-2027 2.1.2 Global HIV Point-of-care Testing Sales 2016-2027 2.2 Global HIV Point-of-care Testing, Market Size by Region: 2016 VS 2021 VS 2027 2.3 HIV Point-of-care Testing Historical Market Size by Region (2016-2021) 2.3.1 Global HIV Point-of-care Testing Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global HIV Point-of-care Testing Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 HIV Point-of-care Testing Market Estimates and Projections by Region (2022-2027) 2.4.1 Global HIV Point-of-care Testing Sales Forecast by Region (2022-2027) 2.4.2 Global HIV Point-of-care Testing Revenue Forecast by Region (2022-2027) 3 Global HIV Point-of-care Testing Competitor Landscape by Players 3.1 Global Top HIV Point-of-care Testing Manufacturers by Sales 3.1.1 Global HIV Point-of-care Testing Sales by Manufacturer (2016-2021) 3.1.2 Global HIV Point-of-care Testing Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top HIV Point-of-care Testing Manufacturers by Revenue 3.2.1 Key HIV Point-of-care Testing Manufacturers Covered: Ranking by Revenue 3.2.2 Global HIV Point-of-care Testing Revenue by Manufacturers (2016-2021) 3.2.3 Global HIV Point-of-care Testing Revenue Share by Manufacturers (2016-2021) 3.2.4 Global HIV Point-of-care Testing Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by HIV Point-of-care Testing Revenue in 2020 3.2.6 Global HIV Point-of-care Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global HIV Point-of-care Testing Price by Manufacturers 3.4 Global HIV Point-of-care Testing Manufacturing Base Distribution, Product Types 3.4.1 HIV Point-of-care Testing Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers HIV Point-of-care Testing Product Type 3.4.3 Date of International Manufacturers Enter into HIV Point-of-care Testing Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global HIV Point-of-care Testing Market Size by Type (2016-2021) 4.1.1 Global HIV Point-of-care Testing Sales by Type (2016-2021) 4.1.2 Global HIV Point-of-care Testing Revenue by Type (2016-2021) 4.1.3 HIV Point-of-care Testing Average Selling Price (ASP) by Type (2016-2021) 4.2 Global HIV Point-of-care Testing Market Size Forecast by Type (2022-2027) 4.2.1 Global HIV Point-of-care Testing Sales Forecast by Type (2022-2027) 4.2.2 Global HIV Point-of-care Testing Revenue Forecast by Type (2022-2027) 4.2.3 HIV Point-of-care Testing Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global HIV Point-of-care Testing Market Size by Application (2016-2021) 5.1.1 Global HIV Point-of-care Testing Sales by Application (2016-2021) 5.1.2 Global HIV Point-of-care Testing Revenue by Application (2016-2021) 5.1.3 HIV Point-of-care Testing Price by Application (2016-2021) 5.2 HIV Point-of-care Testing Market Size Forecast by Application (2022-2027) 5.2.1 Global HIV Point-of-care Testing Sales Forecast by Application (2022-2027) 5.2.2 Global HIV Point-of-care Testing Revenue Forecast by Application (2022-2027) 5.2.3 Global HIV Point-of-care Testing Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States HIV Point-of-care Testing Market Size YoY Growth 2016-2027 6.1.1 United States HIV Point-of-care Testing Sales YoY Growth 2016-2027 6.1.2 United States HIV Point-of-care Testing Revenue YoY Growth 2016-2027 6.1.3 United States HIV Point-of-care Testing Market Share in Global Market 2016-2027 6.2 United States HIV Point-of-care Testing Market Size by Players (International and Local Players) 6.2.1 United States Top HIV Point-of-care Testing Players by Sales (2016-2021) 6.2.2 United States Top HIV Point-of-care Testing Players by Revenue (2016-2021) 6.3 United States HIV Point-of-care Testing Historic Market Review by Type (2016-2021) 6.3.1 United States HIV Point-of-care Testing Sales Market Share by Type (2016-2021) 6.3.2 United States HIV Point-of-care Testing Revenue Market Share by Type (2016-2021) 6.3.3 United States HIV Point-of-care Testing Price by Type (2016-2021) 6.4 United States HIV Point-of-care Testing Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States HIV Point-of-care Testing Sales Forecast by Type (2022-2027) 6.4.2 United States HIV Point-of-care Testing Revenue Forecast by Type (2022-2027) 6.4.3 United States HIV Point-of-care Testing Price Forecast by Type (2022-2027) 6.5 United States HIV Point-of-care Testing Historic Market Review by Application (2016-2021) 6.5.1 United States HIV Point-of-care Testing Sales Market Share by Application (2016-2021) 6.5.2 United States HIV Point-of-care Testing Revenue Market Share by Application (2016-2021) 6.5.3 United States HIV Point-of-care Testing Price by Application (2016-2021) 6.6 United States HIV Point-of-care Testing Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States HIV Point-of-care Testing Sales Forecast by Application (2022-2027) 6.6.2 United States HIV Point-of-care Testing Revenue Forecast by Application (2022-2027) 6.6.3 United States HIV Point-of-care Testing Price Forecast by Application (2022-2027) 7 North America 7.1 North America HIV Point-of-care Testing Market Size YoY Growth 2016-2027 7.2 North America HIV Point-of-care Testing Market Facts & Figures by Country 7.2.1 North America HIV Point-of-care Testing Sales by Country (2016-2021) 7.2.2 North America HIV Point-of-care Testing Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific HIV Point-of-care Testing Market Size YoY Growth 2016-2027 8.2 Asia Pacific HIV Point-of-care Testing Market Facts & Figures by Region 8.2.1 Asia Pacific HIV Point-of-care Testing Sales by Region (2016-2021) 8.2.2 Asia Pacific HIV Point-of-care Testing Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe HIV Point-of-care Testing Market Size YoY Growth 2016-2027 9.2 Europe HIV Point-of-care Testing Market Facts & Figures by Country 9.2.1 Europe HIV Point-of-care Testing Sales by Country (2016-2021) 9.2.2 Europe HIV Point-of-care Testing Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America HIV Point-of-care Testing Market Size YoY Growth 2016-2027 10.2 Latin America HIV Point-of-care Testing Market Facts & Figures by Country 10.2.1 Latin America HIV Point-of-care Testing Sales by Country (2016-2021) 10.2.2 Latin America HIV Point-of-care Testing Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa HIV Point-of-care Testing Market Size YoY Growth 2016-2027 11.2 Middle East and Africa HIV Point-of-care Testing Market Facts & Figures by Country 11.2.1 Middle East and Africa HIV Point-of-care Testing Sales by Country (2016-2021) 11.2.2 Middle East and Africa HIV Point-of-care Testing Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Abbott 12.1.1 Abbott Corporation Information 12.1.2 Abbott Description and Business Overview 12.1.3 Abbott HIV Point-of-care Testing Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Abbott HIV Point-of-care Testing Products Offered 12.1.5 Abbott Recent Development 12.2 BD 12.2.1 BD Corporation Information 12.2.2 BD Description and Business Overview 12.2.3 BD HIV Point-of-care Testing Sales, Revenue and Gross Margin (2016-2021) 12.2.4 BD HIV Point-of-care Testing Products Offered 12.2.5 BD Recent Development 12.3 Biomerieux 12.3.1 Biomerieux Corporation Information 12.3.2 Biomerieux Description and Business Overview 12.3.3 Biomerieux HIV Point-of-care Testing Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Biomerieux HIV Point-of-care Testing Products Offered 12.3.5 Biomerieux Recent Development 12.4 Adaltis 12.4.1 Adaltis Corporation Information 12.4.2 Adaltis Description and Business Overview 12.4.3 Adaltis HIV Point-of-care Testing Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Adaltis HIV Point-of-care Testing Products Offered 12.4.5 Adaltis Recent Development 12.5 Roche 12.5.1 Roche Corporation Information 12.5.2 Roche Description and Business Overview 12.5.3 Roche HIV Point-of-care Testing Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Roche HIV Point-of-care Testing Products Offered 12.5.5 Roche Recent Development 12.11 Abbott 12.11.1 Abbott Corporation Information 12.11.2 Abbott Description and Business Overview 12.11.3 Abbott HIV Point-of-care Testing Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Abbott HIV Point-of-care Testing Products Offered 12.11.5 Abbott Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 HIV Point-of-care Testing Industry Trends 13.2 HIV Point-of-care Testing Market Drivers 13.3 HIV Point-of-care Testing Market Challenges 13.4 HIV Point-of-care Testing Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 HIV Point-of-care Testing Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
SummaryHIV Point-of-care Testing is used to screen HIV antibodies. They can be performed in hospitals, clinics, and home care settings, and the results of these tests are available within a few minutes. Table of Contents1 Study Coverage1.1 HIV Point-of-care Testing Product Introduction 1.2 Market by Type 1.2.1 Global HIV Point-of-care Testing Market Size Growth Rate by Type 1.2.2 Testing Equipment 1.2.3 Testing Reagent 1.3 Market by Application 1.3.1 Global HIV Point-of-care Testing Market Size Growth Rate by Application 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Home Care Setting 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global HIV Point-of-care Testing Market Size, Estimates and Forecasts 2.1.1 Global HIV Point-of-care Testing Revenue 2016-2027 2.1.2 Global HIV Point-of-care Testing Sales 2016-2027 2.2 Global HIV Point-of-care Testing, Market Size by Region: 2016 VS 2021 VS 2027 2.3 HIV Point-of-care Testing Historical Market Size by Region (2016-2021) 2.3.1 Global HIV Point-of-care Testing Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global HIV Point-of-care Testing Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 HIV Point-of-care Testing Market Estimates and Projections by Region (2022-2027) 2.4.1 Global HIV Point-of-care Testing Sales Forecast by Region (2022-2027) 2.4.2 Global HIV Point-of-care Testing Revenue Forecast by Region (2022-2027) 3 Global HIV Point-of-care Testing Competitor Landscape by Players 3.1 Global Top HIV Point-of-care Testing Manufacturers by Sales 3.1.1 Global HIV Point-of-care Testing Sales by Manufacturer (2016-2021) 3.1.2 Global HIV Point-of-care Testing Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top HIV Point-of-care Testing Manufacturers by Revenue 3.2.1 Key HIV Point-of-care Testing Manufacturers Covered: Ranking by Revenue 3.2.2 Global HIV Point-of-care Testing Revenue by Manufacturers (2016-2021) 3.2.3 Global HIV Point-of-care Testing Revenue Share by Manufacturers (2016-2021) 3.2.4 Global HIV Point-of-care Testing Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by HIV Point-of-care Testing Revenue in 2020 3.2.6 Global HIV Point-of-care Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global HIV Point-of-care Testing Price by Manufacturers 3.4 Global HIV Point-of-care Testing Manufacturing Base Distribution, Product Types 3.4.1 HIV Point-of-care Testing Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers HIV Point-of-care Testing Product Type 3.4.3 Date of International Manufacturers Enter into HIV Point-of-care Testing Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global HIV Point-of-care Testing Market Size by Type (2016-2021) 4.1.1 Global HIV Point-of-care Testing Sales by Type (2016-2021) 4.1.2 Global HIV Point-of-care Testing Revenue by Type (2016-2021) 4.1.3 HIV Point-of-care Testing Average Selling Price (ASP) by Type (2016-2021) 4.2 Global HIV Point-of-care Testing Market Size Forecast by Type (2022-2027) 4.2.1 Global HIV Point-of-care Testing Sales Forecast by Type (2022-2027) 4.2.2 Global HIV Point-of-care Testing Revenue Forecast by Type (2022-2027) 4.2.3 HIV Point-of-care Testing Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global HIV Point-of-care Testing Market Size by Application (2016-2021) 5.1.1 Global HIV Point-of-care Testing Sales by Application (2016-2021) 5.1.2 Global HIV Point-of-care Testing Revenue by Application (2016-2021) 5.1.3 HIV Point-of-care Testing Price by Application (2016-2021) 5.2 HIV Point-of-care Testing Market Size Forecast by Application (2022-2027) 5.2.1 Global HIV Point-of-care Testing Sales Forecast by Application (2022-2027) 5.2.2 Global HIV Point-of-care Testing Revenue Forecast by Application (2022-2027) 5.2.3 Global HIV Point-of-care Testing Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States HIV Point-of-care Testing Market Size YoY Growth 2016-2027 6.1.1 United States HIV Point-of-care Testing Sales YoY Growth 2016-2027 6.1.2 United States HIV Point-of-care Testing Revenue YoY Growth 2016-2027 6.1.3 United States HIV Point-of-care Testing Market Share in Global Market 2016-2027 6.2 United States HIV Point-of-care Testing Market Size by Players (International and Local Players) 6.2.1 United States Top HIV Point-of-care Testing Players by Sales (2016-2021) 6.2.2 United States Top HIV Point-of-care Testing Players by Revenue (2016-2021) 6.3 United States HIV Point-of-care Testing Historic Market Review by Type (2016-2021) 6.3.1 United States HIV Point-of-care Testing Sales Market Share by Type (2016-2021) 6.3.2 United States HIV Point-of-care Testing Revenue Market Share by Type (2016-2021) 6.3.3 United States HIV Point-of-care Testing Price by Type (2016-2021) 6.4 United States HIV Point-of-care Testing Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States HIV Point-of-care Testing Sales Forecast by Type (2022-2027) 6.4.2 United States HIV Point-of-care Testing Revenue Forecast by Type (2022-2027) 6.4.3 United States HIV Point-of-care Testing Price Forecast by Type (2022-2027) 6.5 United States HIV Point-of-care Testing Historic Market Review by Application (2016-2021) 6.5.1 United States HIV Point-of-care Testing Sales Market Share by Application (2016-2021) 6.5.2 United States HIV Point-of-care Testing Revenue Market Share by Application (2016-2021) 6.5.3 United States HIV Point-of-care Testing Price by Application (2016-2021) 6.6 United States HIV Point-of-care Testing Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States HIV Point-of-care Testing Sales Forecast by Application (2022-2027) 6.6.2 United States HIV Point-of-care Testing Revenue Forecast by Application (2022-2027) 6.6.3 United States HIV Point-of-care Testing Price Forecast by Application (2022-2027) 7 North America 7.1 North America HIV Point-of-care Testing Market Size YoY Growth 2016-2027 7.2 North America HIV Point-of-care Testing Market Facts & Figures by Country 7.2.1 North America HIV Point-of-care Testing Sales by Country (2016-2021) 7.2.2 North America HIV Point-of-care Testing Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific HIV Point-of-care Testing Market Size YoY Growth 2016-2027 8.2 Asia Pacific HIV Point-of-care Testing Market Facts & Figures by Region 8.2.1 Asia Pacific HIV Point-of-care Testing Sales by Region (2016-2021) 8.2.2 Asia Pacific HIV Point-of-care Testing Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe HIV Point-of-care Testing Market Size YoY Growth 2016-2027 9.2 Europe HIV Point-of-care Testing Market Facts & Figures by Country 9.2.1 Europe HIV Point-of-care Testing Sales by Country (2016-2021) 9.2.2 Europe HIV Point-of-care Testing Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America HIV Point-of-care Testing Market Size YoY Growth 2016-2027 10.2 Latin America HIV Point-of-care Testing Market Facts & Figures by Country 10.2.1 Latin America HIV Point-of-care Testing Sales by Country (2016-2021) 10.2.2 Latin America HIV Point-of-care Testing Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa HIV Point-of-care Testing Market Size YoY Growth 2016-2027 11.2 Middle East and Africa HIV Point-of-care Testing Market Facts & Figures by Country 11.2.1 Middle East and Africa HIV Point-of-care Testing Sales by Country (2016-2021) 11.2.2 Middle East and Africa HIV Point-of-care Testing Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Abbott 12.1.1 Abbott Corporation Information 12.1.2 Abbott Description and Business Overview 12.1.3 Abbott HIV Point-of-care Testing Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Abbott HIV Point-of-care Testing Products Offered 12.1.5 Abbott Recent Development 12.2 BD 12.2.1 BD Corporation Information 12.2.2 BD Description and Business Overview 12.2.3 BD HIV Point-of-care Testing Sales, Revenue and Gross Margin (2016-2021) 12.2.4 BD HIV Point-of-care Testing Products Offered 12.2.5 BD Recent Development 12.3 Biomerieux 12.3.1 Biomerieux Corporation Information 12.3.2 Biomerieux Description and Business Overview 12.3.3 Biomerieux HIV Point-of-care Testing Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Biomerieux HIV Point-of-care Testing Products Offered 12.3.5 Biomerieux Recent Development 12.4 Adaltis 12.4.1 Adaltis Corporation Information 12.4.2 Adaltis Description and Business Overview 12.4.3 Adaltis HIV Point-of-care Testing Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Adaltis HIV Point-of-care Testing Products Offered 12.4.5 Adaltis Recent Development 12.5 Roche 12.5.1 Roche Corporation Information 12.5.2 Roche Description and Business Overview 12.5.3 Roche HIV Point-of-care Testing Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Roche HIV Point-of-care Testing Products Offered 12.5.5 Roche Recent Development 12.11 Abbott 12.11.1 Abbott Corporation Information 12.11.2 Abbott Description and Business Overview 12.11.3 Abbott HIV Point-of-care Testing Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Abbott HIV Point-of-care Testing Products Offered 12.11.5 Abbott Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 HIV Point-of-care Testing Industry Trends 13.2 HIV Point-of-care Testing Market Drivers 13.3 HIV Point-of-care Testing Market Challenges 13.4 HIV Point-of-care Testing Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 HIV Point-of-care Testing Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
QYResearch社の分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2025/05/09 10:26 146.82 円 165.12 円 196.98 円 |